Congratulations to Dr. Andrea Casiraghi for being named as a 2023 Convergence Scholar. Learn more about the program and the impressive 2023 cohort here: https://www.nanomedicine.mit.edu/the-convergence-scholars-program
The Koehler Lab aims to innovate in the earliest stages of drug discovery by building chemical tools or technologies to assist in the process of target validation and by expanding the repertoire of protein targets that are considered to be druggable. We focus primarily on building chemical tools and methods for studying temporal aspects of transcriptional regulation in development and disease with a focus on cancer.
The Koehler Lab is supported through the generosity of our public and private funding partners.
We will gladly accommodate requests for greater accessibility of public content.
